BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29293)

  • 1. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.
    Pentchev PG; Brady RO; Blair HE; Britton DE; Sorrell SH
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3970-3. PubMed ID: 29293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
    Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
    Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease.
    Peters SP; Coffee CJ; Glew RH; Lee RE; Wenger DA; Li SC; Li YT
    Arch Biochem Biophys; 1977 Sep; 183(1):290-7. PubMed ID: 907355
    [No Abstract]   [Full Text] [Related]  

  • 4. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Eur J Biochem; 1981 Apr; 115(3):455-61. PubMed ID: 6786882
    [No Abstract]   [Full Text] [Related]  

  • 5. The assay of glucocerebrosidase activity using the natural substrata.
    Strasberg PM; Lowden JA
    Clin Chim Acta; 1982 Jan; 118(1):9-20. PubMed ID: 7053909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization of the heat-stable glucocerebrosidase activator substance in Gaucher spleen.
    Chiao YB; Chambers JP; Glew RH; Lee RE; Wenger DA
    Arch Biochem Biophys; 1978 Feb; 186(1):42-51. PubMed ID: 629536
    [No Abstract]   [Full Text] [Related]  

  • 7. Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease.
    Aerts JM; Sa Miranda MC; Brouwer-Kelder EM; Van Weely S; Barranger JA; Tager JM
    Biochim Biophys Acta; 1990 Oct; 1041(1):55-63. PubMed ID: 2223847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.
    Peters SP; Coyle P; Coffee CJ; Glew RH
    J Biol Chem; 1977 Jan; 252(2):563-73. PubMed ID: 13071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.
    Pentchev PG; Neumeyer B; Svennerholm L; Groth CG; Brady RO
    Am J Hum Genet; 1983 Jul; 35(4):621-8. PubMed ID: 6881138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY
    Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
    Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
    Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
    Prence EM; Garrett KO; Glew RH
    Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
    Peters SP; Coyle P; Glew RH
    Arch Biochem Biophys; 1976 Aug; 175(2):569-82. PubMed ID: 958319
    [No Abstract]   [Full Text] [Related]  

  • 14. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
    Choy FY
    Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enzymatic defect in Gaucher disease.
    Brady RO
    Prog Clin Biol Res; 1982; 95():309-14. PubMed ID: 7122638
    [No Abstract]   [Full Text] [Related]  

  • 16. High-resolution proton nuclear magnetic resonance studies of the glucocerebrosidase activator protein from Gaucher spleen.
    Sheh L; Glew RH; Bothner-By AA; Mishra PK
    Biochemistry; 1985 Nov; 24(23):6645-51. PubMed ID: 4084549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A; Glew RH; Daniels LB; Clark LS
    J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a heat-stable factor in human spleen on glucocerebrosidase and acid -glucosidase activities.
    Pentchev PG; Brady RO
    Biochim Biophys Acta; 1973 Feb; 297(2):491-6. PubMed ID: 4705477
    [No Abstract]   [Full Text] [Related]  

  • 19. Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen.
    Prence E; Chakravorti S; Basu A; Clark LS; Glew RH; Chambers JA
    Arch Biochem Biophys; 1985 Jan; 236(1):98-109. PubMed ID: 3966805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
    Prence EM; Garrett KO; Panitch H; Basu A; Glew RH; Wherrett JR; Huterer S
    Clin Chim Acta; 1986 Apr; 156(2):179-89. PubMed ID: 3085988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.